Am. Liese et al., Augmented TNF-alpha and IL-10 production by primed human monocytes following interaction with oxidatively modified autologous erythrocytes, J LEUK BIOL, 70(2), 2001, pp. 289-296
The presence of dysfunctional/damaged red blood cells (RBCs) has been assoc
iated with adverse clinical effects during the inflammatory response. The a
im of this study was to elucidate whether oxidatively modified, autologous,
RBCs modulate monocyte cytokine responses in humans. Monocyte tumor necros
is factor alpha (TNF-alpha) and IL-10 production was measured in whole bloo
d from healthy volunteers using ELISA and flow cytometry. Oxidatively modif
ied RBCs (15 m.M phenylhydrazine, 1 h, OX-RBQ or vehicle-treated RBCs (VT-R
BC) opsonized by autologous serum were administered alone or in combination
with one of three priming agents: E. coli lipopolysaccharide (LPS, 0.2 ng/
ml), zymosan A (1 mg/ml), or phorbol 12-myristate 13-acetate (PMA, 50 ng/ml
). OX-RBC or W-RBC alone did not result in the release of TNF-alpha or IL-1
0. LPS, zymosan, and PMA caused marked and dose-dependent increases in TNF-
alpha and IL-10 production. Addition of OX-RBC augmented the LPS-, zymosan-
, and PMA-induced TNF-alpha release by approximately 100%. OX-RBC augmented
LPS- and zymosan-mduced IL-10 release by 400-600%. Flow cytometry analyses
showed that monocytes were responsible for TNF-alpha and IL-10 production
in whole blood. The presence of OX-RBC alone increased the complexity of CD
14+ monocytes but caused no cytokine production. LPS alone induced cytokine
production without altering cell complexity. After the combined (OX-RBC+LP
S) treatment, monocytes of high complexity were responsible for TNF-alpha p
roduction. The presence of mannose or galactose (at 10-50 mM) did not alter
the observed augmentation of cytokine production by OX-RBC, suggesting tha
t lectin receptors are not involved in the response. These studies indicate
that the interaction between damaged autologous erythrocytes and monocytes
has a major impact on the cytokine responses in human. An augmented cytoki
ne production by the mononuclear phagocyte system may adversely affect the
clinical course of injury and infections especially in genetic or acquired
RBC diseases or after transfusions.